These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 19907105)
1. Effects of pitavastatin (LIVALO Tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia. Teramoto T; Shimano H; Yokote K; Urashima M J Atheroscler Thromb; 2009 Oct; 16(5):654-61. PubMed ID: 19907105 [TBL] [Abstract][Full Text] [Related]
2. Pitavastatin: clinical effects from the LIVES Study. Teramoto T Atheroscler Suppl; 2011 Nov; 12(3):285-8. PubMed ID: 22152283 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia. Saito Y; Yamada N; Teramoto T; Itakura H; Hata Y; Nakaya N; Mabuchi H; Tushima M; Sasaki J; Ogawa N; Goto Y Atherosclerosis; 2002 Jun; 162(2):373-9. PubMed ID: 11996957 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia. Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077 [TBL] [Abstract][Full Text] [Related]
5. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [TBL] [Abstract][Full Text] [Related]
6. The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-C. Teramoto T Expert Opin Pharmacother; 2012 Apr; 13(6):859-65. PubMed ID: 22332608 [TBL] [Abstract][Full Text] [Related]
7. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia. Park S; Kang HJ; Rim SJ; Ha JW; Oh BH; Chung N; Cho SY Clin Ther; 2005 Jul; 27(7):1074-82. PubMed ID: 16154486 [TBL] [Abstract][Full Text] [Related]
8. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin. da Silva PM Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776 [TBL] [Abstract][Full Text] [Related]
10. Effects of pitavastatin (LIVALO tablet) on the estimated glomerular filtration rate (eGFR) in hypercholesterolemic patients with chronic kidney disease. Sub-analysis of the LIVALO Effectiveness and Safety (LIVES) Study. Kimura K; Shimano H; Yokote K; Urashima M; Teramoto T J Atheroscler Thromb; 2010 Jun; 17(6):601-9. PubMed ID: 20460830 [TBL] [Abstract][Full Text] [Related]
11. Pitavastatin: an overview. Saito Y Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of pitavastatin in Japanese patients with hypercholesterolemia: LIVES study and subanalysis. Yokote K; Shimano H; Urashima M; Teramoto T Expert Rev Cardiovasc Ther; 2011 May; 9(5):555-62. PubMed ID: 21615316 [TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia. Sansanayudh N; Wongwiwatthananukit S; Putwai P; Dhumma-Upakorn R Ann Pharmacother; 2010 Mar; 44(3):415-23. PubMed ID: 20179259 [TBL] [Abstract][Full Text] [Related]
14. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study. Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H; J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789 [TBL] [Abstract][Full Text] [Related]
15. High density lipoprotein cholesterol and apolipoprotein A-I are persistently elevated during long-term treatment with pitavastatin, a new HMG-CoA reductase inhibitor. Fukutomi T; Takeda Y; Suzuki S; Ito T; Joh T; Itoh M Int J Cardiol; 2010 Jun; 141(3):320-2. PubMed ID: 19138801 [TBL] [Abstract][Full Text] [Related]
16. Pitavastatin reduces elevated IL-18 levels in Japanese subjects with hypercholesterolemia: sub-analysis of Kansai investigation of statin for hyperlipidemic intervention in metabolism and endocrinology (KISHIMEN). Fujioka Y; Fukuda A; Ishida T; Kagimoto S; Nakamura Y; Iwakura A; Hara K; Yamamoto T; Kuroe A; Ohya M; Fujimoto S; Hamamoto Y; Honjo S; Ikeda H; Nabe K; Tsuda K; Taniguchi A; Tanaka K; Koshiyama H; Kume N; Hirata K J Atheroscler Thromb; 2011; 18(1):8-15. PubMed ID: 20940516 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Pitavastatin in Japanese Male Children with Familial Hypercholesterolemia. Harada-Shiba M; Arisaka O; Ohtake A; Okada T; Suganami H; J Atheroscler Thromb; 2016; 23(1):48-55. PubMed ID: 25891210 [TBL] [Abstract][Full Text] [Related]
18. New evidence on pitavastatin: efficacy and safety in clinical studies. Teramoto T; Shimano H; Yokote K; Urashima M Expert Opin Pharmacother; 2010 Apr; 11(5):817-28. PubMed ID: 20201733 [TBL] [Abstract][Full Text] [Related]
19. [The efficacy and safety of pitavastatin]. Sansoy V Turk Kardiyol Dern Ars; 2017 Apr; 45(Suppl 3):1-4. PubMed ID: 28952470 [TBL] [Abstract][Full Text] [Related]
20. Pitavastatin: A Review in Hypercholesterolemia. Hoy SM Am J Cardiovasc Drugs; 2017 Apr; 17(2):157-168. PubMed ID: 28130659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]